NR1H4 and renal fibrosis: Specifically, alisol B 23-acetate has been shown to activate renal farnesoid X receptor (FXR), providing renoprotection against ischemia–reperfusion injury and alleviating renal fibrosis through mechanisms such as gut microbiome modulation and blood pressure regulation [24,25].